Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) dropped 3.6% during trading on Tuesday . The company traded as low as $4.28 and last traded at $4.32. Approximately 27,678 shares changed hands during trading, a decline of 86% from the average daily volume of 200,144 shares. The stock had previously closed at $4.48.
Aveanna Healthcare Stock Performance
The stock has a market capitalization of $854.05 million, a PE ratio of -13.00 and a beta of 2.20. The stock's 50-day moving average price is $5.27 and its two-hundred day moving average price is $4.57.
Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last announced its earnings results on Thursday, November 7th. The company reported $0.02 earnings per share for the quarter, beating analysts' consensus estimates of ($0.01) by $0.03. The business had revenue of $509.02 million for the quarter, compared to the consensus estimate of $495.80 million. During the same period in the prior year, the business posted ($0.05) EPS. On average, analysts predict that Aveanna Healthcare Holdings Inc. will post -0.08 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Aveanna Healthcare
Several institutional investors and hedge funds have recently modified their holdings of the stock. Geode Capital Management LLC raised its holdings in Aveanna Healthcare by 4.7% in the third quarter. Geode Capital Management LLC now owns 1,401,016 shares of the company's stock worth $7,287,000 after buying an additional 63,190 shares during the last quarter. State Street Corp raised its holdings in Aveanna Healthcare by 0.9% in the 3rd quarter. State Street Corp now owns 1,039,920 shares of the company's stock worth $5,408,000 after acquiring an additional 9,446 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in Aveanna Healthcare by 3.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 462,659 shares of the company's stock valued at $2,406,000 after acquiring an additional 17,522 shares in the last quarter. Jacobs Levy Equity Management Inc. boosted its stake in Aveanna Healthcare by 297.6% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 355,340 shares of the company's stock valued at $1,848,000 after purchasing an additional 265,969 shares during the last quarter. Finally, Renaissance Technologies LLC raised its stake in shares of Aveanna Healthcare by 155.8% in the second quarter. Renaissance Technologies LLC now owns 158,600 shares of the company's stock worth $438,000 after purchasing an additional 96,600 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors.
About Aveanna Healthcare
(
Get Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Further Reading
Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
